Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FLEXIQULE is a herbal dietary supplement developed by AlchemLife for the management of joint pain and symptoms associated with osteoarthritis and rheumatoid arthritis. It is formulated as a softgel capsule containing standardized extracts of Boswellia serrata (Indian frankincense) and ginger (Zingiber officinale). The product utilizes a proprietary PhytoAdvance extraction technology to isolate active phytochemicals, specifically boswellic acids and gingerols. These compounds exert anti-inflammatory effects by inhibiting the 5-lipoxygenase (5-LO) enzyme and acting as COX-2 inhibitors, thereby reducing inflammation and protecting against cartilage degradation. Clinical studies have demonstrated that the supplement provides significant relief in joint discomfort and improved mobility in various joints, including the knee, back, and neck.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FLEXIQULE.